The impact of pharmaceutical innovation on cancer mortality in Mexico, 2003–2013

Frank Lichtenberg

Latin American Economic Review, 2017, vol. 26, issue 1, 1-22

Abstract: Abstract I assess the impact that pharmaceutical innovation had on cancer mortality in Mexico during the period 2003–2013, by investigating whether there were larger declines in the age-standardized mortality rate of cancer sites (breast, lung, colon, etc.) that were subject to more pharmaceutical innovation, controlling for changes in the age-standardized cancer incidence rate. The estimates indicate that new drugs launched during 1991–2001 reduced the age-standardized cancer mortality rate by 16%, i.e., at an average annual rate of about 1.6%. I estimate that 105,661 life-years before age 70 were gained in 2013 due to cancer drugs launched during 1991–2001, and that the cost per life-year gained was in the neighborhood of $2146. By the standards of the World Health Organization, new cancer drugs have been very cost-effective in Mexico. The contribution of cancer drug innovation to Mexican longevity growth has been valuable, but, perhaps, it could have been even larger. Only half as many new cancer drugs were launched in Mexico during 2010–2014 as were launched in the US. In addition, when new drugs are launched in Mexico, their diffusion tends to be quite slow.

Keywords: Pharmaceutical; Innovation; Mortality; Longevity; Cancer; Mexico; Cost-effectiveness (search for similar items in EconPapers)
JEL-codes: I1 J11 L65 O33 (search for similar items in EconPapers)
Date: 2017
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://link.springer.com/10.1007/s40503-017-0045-6 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:laecrv:v:26:y:2017:i:1:d:10.1007_s40503-017-0045-6

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/40503

DOI: 10.1007/s40503-017-0045-6

Access Statistics for this article

Latin American Economic Review is currently edited by Susan W. Parker, Kaniska Dam and Gonzalo Castañeda

More articles in Latin American Economic Review from Springer, Centro de Investigaciòn y Docencia Económica (CIDE)
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().